Reference Library: Anemia Management - Erythropoietic Agents

Target Haemoglobin to Aim for with Erythropoiesis-Stimulating Agents: A Position Statement By ERBP Following Publication of the Trial to Reduce Cardiovascular Events with Aranesp® Therapy (TREAT) Study
Date: Thursday, August 5th, 2010
based on 1 reader · Rate this article

Erythropoietin Preserves the Integrity and Quality of Organs for Transplantation After Cardiac Death
Date: Thursday, July 22nd, 2010
based on 0 readers · Rate this article

The Preoperative Use of Erythropoietin Stimulating Proteins Prior to Radical Prostatectomy is Not Associated with Increased Cardiovascular or Thromboembolic Morbidity or Mortality
Date: Thursday, July 22nd, 2010
based on 0 readers · Rate this article

Erythropoietin Preserves the Integrity and Quality of Organs for Transplantation After Cardiac Death
Date: Wednesday, July 14th, 2010
based on 0 readers · Rate this article

The Preoperative Use of Erythropoietin Stimulating Proteins Prior to Radical Prostatectomy is Not Associated with Increased Cardiovascular or Thromboembolic Morbidity or Mortality
Date: Wednesday, July 14th, 2010
based on 0 readers · Rate this article

Erythropoiesis-Stimulating Agents for Anemia in Chronic Heart Failure Patients
Date: Wednesday, May 12th, 2010
based on 1 reader · Rate this article

Impact of limiting erythropoiesis-stimulating agent use for chemotherapy-induced anemia on the United States blood supply margin
Date: Thursday, April 1st, 2010
based on 0 readers · Rate this article

Erythropoiesis-Stimulating Agents in Oncology: A Study-Level Meta-Analysis of Survival and Other Safety Outcomes
Date: Wednesday, March 24th, 2010
based on 1 reader · Rate this article

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease
Date: Monday, March 1st, 2010
based on 0 readers · Rate this article

Effects of chemotherapy on endogenous erythropoietin levels and the pharmacokinetics and erythropoietic response of darbepoetin alfa: a randomised clinical trial of synchronous versus asynchronous dosing of darbepoetin alfa
Date: Monday, March 1st, 2010
based on 0 readers · Rate this article

Efficacy of preoperative recombinant human erythropoietin administration for reducing transfusion requirements in patients undergoing surgery for hip fracture repair. An observational cohort study
Date: Monday, March 1st, 2010
based on 0 readers · Rate this article

Epoetin alfa versus darbepoetin alfa in chemotherapy-related anemia
Date: Monday, March 1st, 2010
based on 0 readers · Rate this article

Erythropoiesis-stimulating agents: favorable safety profile when used as indicated
Date: Monday, March 1st, 2010
based on 0 readers · Rate this article

Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha
Date: Monday, March 1st, 2010
based on 0 readers · Rate this article

The effect of recombinant human erythropoietin on platelet counts is strongly modulated by the adequacy of iron supply
Date: Monday, March 1st, 2010
based on 0 readers · Rate this article

Use of erythropoiesis stimulating agents and intravenous iron for cancer and treatment-related anaemia: the need for predictors and indicators of effectiveness has not abated
Date: Monday, March 1st, 2010
based on 0 readers · Rate this article

What is the right balance between iron and erythropoiesis stimulating agents in chemotherapy induced anemia?
Date: Monday, March 1st, 2010
based on 0 readers · Rate this article

Can Intravenous Iron Therapy Meet the Unmet Needs Created by the New Restrictions on Erythropoietic Stimulating Agents?
Date: Wednesday, December 23rd, 2009
based on 1 reader · Rate this article

A Peptide-Based Erythropoietin-Receptor Agonist for Pure Red-Cell Aplasia
Date: Wednesday, December 9th, 2009
based on 1 reader · Rate this article

Erythropoiesis Stimulating Agents in Heart Failure Patients with Anemia: A Meta-Analysis
Date: Wednesday, December 2nd, 2009
based on 1 reader · Rate this article

Erythropoiesis Stimulating Agent Administration Improves Survival After Severe Traumatic Brain Injury: A Matched Case Control Study
Date: Wednesday, November 4th, 2009
based on 1 reader · Rate this article

Erythropoietin in Patients with Acute Coronary Syndrome and Its Cardioprotective Action after Percutaneous Coronary Intervention
Date: Wednesday, October 14th, 2009
based on 2 readers · Rate this article

Erythropoietin or Darbepoetin for Patients with Cancer - Meta-analysis Based on Individual Patient Data (Review)
Date: Wednesday, September 2nd, 2009
based on 2 readers · Rate this article

Red Blood Cell Use Outside the Operating Theater: A Prospective Observational Study with Modeling of Potential Blood Conservation during Severe Blood Shortages
Date: Wednesday, August 5th, 2009
based on 1 reader · Rate this article

The Importance of Iron in Long-Term Survival of Maintenance Hemodialysis Patients Treated with Epoetin-alfa and Intravenous Iron: Analysis of 9.5 Years of Prospectively Collected Data
Date: Wednesday, July 8th, 2009
based on 1 reader · Rate this article

Current and Upcoming Erythropoiesis-Stimulating Agents, Iron Products, and Other Novel Anemia Medications
Date: Tuesday, May 19th, 2009
based on 1 reader · Rate this article

Pharmacokinetics and Pharmacodynamics of Six Epoetin Alfa Dosing Regimens in Anemic Critically Ill Patients without Acute Blood Loss
Date: Tuesday, April 14th, 2009
based on 3 readers · Rate this article

A Risk Model for Severe Anemia to Select Cancer Patients for Primary Prophylaxis with Epoetin α: A Prospective Randomized Controlled Trial of the ELYPSE Study Group
Date: Tuesday, March 10th, 2009
based on 3 readers · Rate this article

Blood Transfusion Reduction in Cardiac Surgery: Multidisciplinary Approach at a Community Hospital
Date: Tuesday, March 3rd, 2009
based on 3 readers · Rate this article

A US Multicenter, Retrospective, Observational Study of Erythropoiesis-Stimulating Agent Utilization in Anemic, Critically Ill Patients Admitted to the Intensive Care Unit
Date: Friday, February 27th, 2009
based on 0 readers · Rate this article

The Role of Erythropoietin in the Acute Phase of Trauma Management: Evidence Today
Date: Tuesday, February 17th, 2009
based on 2 readers · Rate this article

Anemia of Chronic Disease: A Harmful Disorder or an Adaptive, Beneficial Response?
Date: Tuesday, October 21st, 2008
based on 5 readers · Rate this article

A Phase I/II Trial of High-Dose Erythropoietin in Extremely Low Birth Weight Infants: Pharmacokinetics and Safety
Date: Tuesday, September 23rd, 2008
based on 1 reader · Rate this article

Improved Survival of Critically Ill Trauma Patients Treated with Recombinant Human Erythropoietin
Date: Wednesday, August 20th, 2008
based on 2 readers · Rate this article

Continuing Reassessment of the Risks of Erythropoiesis-Stimulating Agents in Patients with Cancer
Date: Wednesday, July 2nd, 2008
based on 2 readers · Rate this article

Incidence of Symptomatic Deep Venous Thrombosis with Epoetin Alfa or Darbepoetin Alfa Treatment of Anemia in Patients with Ovarian or Primary Peritoneal Cancer
Date: Monday, June 4th, 2007
based on 5 readers · Rate this article

A Randomized, Parallel-Group, Open-Label Trial of Recombinant Human Erythropoietin vs Preoperative Autologous Donation in Primary Total Joint Arthroplasty Effect on Postoperative Vigor and Handgrip Strength
Date: Monday, April 23rd, 2007
based on 7 readers · Rate this article

Speed of Hemoglobin Response in Patients with Cancer: A Review of the Erythropoietic Proteins
Date: Monday, March 12th, 2007
based on 1 reader · Rate this article

Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease
Date: Friday, December 29th, 2006
based on 0 readers · Rate this article

Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
Date: Friday, December 29th, 2006
based on 0 readers · Rate this article

New Approaches to the Management of Anemia of Chronic Kidney Disease: Beyond Epogen and Infed
Date: Friday, December 1st, 2006
based on 0 readers · Rate this article

Influence of Hemoglobin Levels on Inpatient Rehabilitation Outcomes After Total Knee Arthroplasty
Date: Friday, October 6th, 2006
based on 0 readers · Rate this article

Preoperative Epoetin Alfa vs. Autologous Blood Donation in Primary Total Knee Arthroplasty
Date: Friday, October 6th, 2006
based on 0 readers · Rate this article

Double-Blind, Placebo-Controlled Study of Quality of Life, Hematologic End Points, and Safety of Weekly Epoetin Alfa in Children with Cancer Receiving Myelosuppressive Chemotherapy
Date: Tuesday, September 5th, 2006
based on 0 readers · Rate this article

Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: A randomized, double-blind, placebo-controlled trial
Date: Saturday, August 26th, 2006
based on 0 readers · Rate this article

Perioperative intravenous iron, with or without erythropoietin, plus restrictive transfusion protocol reduce the need for allogeneic blood after knee replacement surgery.
Date: Friday, August 11th, 2006
based on 1 reader · Rate this article

Iron and the Anemia of Chronic Disease: A Review and Strategic Recommendations
Date: Friday, July 7th, 2006
based on 0 readers · Rate this article

Recombinant Human Erythropoietins and Cancer Patients: Updated Meta-Analysis of 57 Studies Including 9353 Patients
Date: Friday, June 16th, 2006
based on 0 readers · Rate this article

Does the Use of Erythropoietin Reduce the Risk of Exposure to Allogeneic Blood Transfusion in Cardiac Surgery? A Systematic Review and Meta-Analysis
Date: Friday, June 9th, 2006
based on 0 readers · Rate this article

Effectiveness of Darbepoetin-Alfa in Combination with Intravenous Iron Sucrose in Patients with Inflammatory Bowel Disease and Refractory Anemia: A Pilot Study
Date: Friday, March 31st, 2006
based on 0 readers · Rate this article

Phase III Study of Two Different Dosing Schedules of Erythropoietin in Anemic Patients with Cancer
Date: Friday, March 24th, 2006
based on 0 readers · Rate this article